AAMAC Webinar - Friday May 22, 2020
Time: 10 am (Pacific Time (PT))
Speaker: Dr Heather Leitch Topic: Brief update on Covid-19 followed by a Q&A THE SPEAKER: Dr. Heather Leitch, Director Hematology/Oncology Research (SPH), Clinical Professor, St. Paul’s Hospital Dr. Heather Leitch completed a PhD in microbiology (leukemia stem cell research) at UBC in 1992. She graduated from medical school at UBC in 1995, trained in internal medicine at UBC, and completed a hematology fellowship at McGill University in 2000, where she also completed course requirements toward a master’s degree in epidemiology and biostatistics. She completed post-fellowship training with the Lymphoma Tumour Group at the B.C. Cancer Agency in 2002, and currently holds the position of Clinical Associate Professor at UBC. Dr. Leitch has been a member of the hematology/oncology group at St. Paul’s Hospital since 2004, and actively participates in research projects and clinical trials with a focus on hematological malignancies. Recent publications co-authored by Dr. Leitch have focused on the treatment of: iron overload in patients with myelodysplastic syndromes (MDS) and other acquired bone marrow failure syndromes; HIV-associated lymphoma; monoclonal B-cell lymphocytosis; and relapsed/refractory myeloma, MDS, and lymphoma. To register email info@aamac.ca or call 1-888-840-0039 |
AAMAC Webinar - Friday May 22, 2020
Time: 11 am (Pacific Time (PT)) (PLEASE NOTE THE TIME CHANGE)
Speaker: Dr Heather Leitch Topic: Brief update on Covid-19 followed by a Q&A THE SPEAKER: Dr. Heather Leitch, Director Hematology/Oncology Research (SPH), Clinical Professor, St. Paul’s Hospital Dr. Heather Leitch completed a PhD in microbiology (leukemia stem cell research) at UBC in 1992. She graduated from medical school at UBC in 1995, trained in internal medicine at UBC, and completed a hematology fellowship at McGill University in 2000, where she also completed course requirements toward a master’s degree in epidemiology and biostatistics. She completed post-fellowship training with the Lymphoma Tumour Group at the B.C. Cancer Agency in 2002, and currently holds the position of Clinical Associate Professor at UBC. Dr. Leitch has been a member of the hematology/oncology group at St. Paul’s Hospital since 2004, and actively participates in research projects and clinical trials with a focus on hematological malignancies. Recent publications co-authored by Dr. Leitch have focused on the treatment of: iron overload in patients with myelodysplastic syndromes (MDS) and other acquired bone marrow failure syndromes; HIV-associated lymphoma; monoclonal B-cell lymphocytosis; and relapsed/refractory myeloma, MDS, and lymphoma. To register:
|
AAMAC Webinar - Friday May 22, 2020
TODAY'S WEBINAR HAS BEEN CANCELLED.
Unfortunately the speaker is unwell. We wish her a speedy recovery. |
All times are GMT -4. The time now is 04:46 AM. |
Powered by vBulletin® Version 3.6.7
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
Forum sites may contain non-authoritative and unverified information.
Medical decisions should be made in consultation with qualified medical professionals.
Site contents exclusive of member posts Copyright © 2006-2020 Marrowforums.org